Rodent models for resolving extremes of exercise and health

Physiological Genomics

Volumn 48, Issue 2, 2016, Pages 82-92

  Garton, Fleur C ^a,b   North, Kathryn N ^a,b   Koch, Lauren G ^c   Britton, Steven L ^c   Nogales Gadea, Gisela ^d   Lucia, Alejandro ^d,e  

^a MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^e UNIVERSIDAD EUROPEA DE MADRID   (Spain)

Author keywords

Disease; Exercise; Genetic loci; Humans; Mice; Performance; Rats

Indexed keywords

ALPHA ACTININ 3; ACTININ; ACTN3 PROTEIN, HUMAN;

ALPHA ACTININ 3 DEFICIENCY; EXERCISE; GENOTYPE ENVIRONMENT INTERACTION; GLYCOGEN STORAGE DISEASE; GLYCOGEN STORAGE DISEASE TYPE 2; GLYCOGEN STORAGE DISEASE TYPE 5; HEALTH STATUS; HUMAN; KNOCKOUT MOUSE; MORBIDITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; RODENT MODEL; TRANSGENIC MOUSE; ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; DEFICIENCY; DISEASE MODEL; MOUSE; PATHOPHYSIOLOGY; RAT;

ACTININ; ANIMALS; DISEASE MODELS, ANIMAL; EXERCISE; GLYCOGEN STORAGE DISEASE TYPE II; GLYCOGEN STORAGE DISEASE TYPE V; HUMANS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MODELS, ANIMAL; PHYSICAL CONDITIONING, ANIMAL; RATS;

EID: 84961295204     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00077.2015     Document Type: Review

References (99)

1. Ahmetov II, Gavrilov DN, Astratenkova IV, Druzhevskaya AM, Malinin AV, Romanova EE, Rogozkin VA. The association of ACE, ACTN3 and PPARA gene variants with strength phenotypes in middle school-age children. J Physiol Sci 63: 79-85, 2013.
2. Akar FG, Aon MA, Tomaselli GF, O’Rourke B. The mitochondrial origin of postischemic arrhythmias. J Clin Invest 115: 3527-3535, 2005.
3. Alfred T, Ben-Shlomo Y, Cooper R, Hardy R, Cooper C, Deary IJ, Gunnell D, Harris SE, Kumari M, Martin RM, Moran CN, Pitsiladis YP, Ring SM, Sayer AA, Smith GD, Starr JM, Kuh D, Day IN. ACTN3 genotype, athletic status, and life course physical capability: meta-analysis of the published literature and findings from nine studies. Hum Mutat 32: 1008-1018, 2011.
4. Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 62: 1198-1211, 1998.
5. Andersen ST, Duno M, Schwartz M, Vissing J. Do carriers of PYGM mutations have symptoms of McArdle disease? Neurology 67: 716-718, 2006.
6. Andreev-Andrievskiy AA, Popova AS, Borovik AS, Dolgov ON, Tsvirkun DV, Custaud M, Vinogradova OL. Stress-associated cardiovas-cular reaction masks heart rate dependence on physical load in mice. Physiol Behav 132: 1-9, 2014.
7. Angelos S, Valberg SJ, Smith BP, McQuarrie PS, Shanske S, Tsujino S, DiMauro S, Cardinet GH 3rd. Myophosphorylase deficiency associated with rhabdomyolysis and exercise intolerance in 6 related Charolais cattle. Muscle Nerve 18: 736-740, 1995.
8. Baldwin JE, Krebs H. The evolution of metabolic cycles. Nature 291: 381-382, 1981.
9. Berndt SI, Gustafsson S, Magi R, Ganna A, Wheeler E, Feitosa MF, Justice AE, Monda KL, Croteau-Chonka DC, Day FR, Esko T, Fall T, Ferreira T, Gentilini D, Jackson AU, Luan J, Randall JC, Vedantam S, Willer CJ, Winkler TW, et al. Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet 45: 501-512, 2013.
10. Bhengu L, Davidson A, du Toit P, Els C, Gerntholtz T, Govendrageloo K, Henderson B, Mubaiwa L, Varughese S. Diagnosis and management of Pompe disease. S Afr Med J 104: 273-274, 2014.
11. 2 max response to exercise training: results from the Heritage family study. J Appl Physiol 87: 1003-1008, 1999.
12. Bowman TA, Ramakrishnan SK, Kaw M, Lee SJ, Patel PR, Golla VK, Bourey RE, Haram PM, Koch LG, Britton SL, Wisløff U, Lee AD, Najjar SM. Caloric restriction reverses hepatic insulin resistance and steatosis in rats with low aerobic capacity. Endocrinology 151: 5157-5164, 2010.
13. Broos S, Malisoux L, Theisen D, Francaux M, Deldicque L, Thomis MA. Role of alpha-actinin-3 in contractile properties of human single muscle fibers: a case series study in paraplegics. PLoS One 7: e49281, 2012.
14. Broos S, Van Leemputte M, Deldicque L, Thomis MA. History-dependent force, angular velocity and muscular endurance in ACTN3 genotypes. Eur J Appl Physiol 115: 1637-1643, 2015.
15. Brull A, de Luna N, Blanco-Grau A, Lucia A, Martin MA, Arenas J, Marti R, Andreu AL, Pinos T. Phenotype consequences of myophos-phorylase dysfunction: insights from the McArdle mouse model. J Physiol 593: 2693-2706, 2015.
16. 2+-stimulated mitochondrial biogenesis in muscle fibers of cold-acclimated mice. J Physiol 588: 4275-4288, 2010.
17. Chan Y, Tong H, Beggs AH, Kunkel LM. Human skeletal muscle-specific α-actinin-2 and-3 isoforms form homodimers and heterodimers in vitro and in vivo. Biochem Biophys Res Commun 248: 134-139, 1998.
18. Chodzko-Zajko WJ, Proctor DN, Fiatarone Singh MA, Minson CT, Nigg CR, Salem GJ, Skinner JS. American College of Sports Medicine position stand. Exercise and physical activity for older adults. Med Sci Sports Exerc 41: 1510-1530, 2009.
19. Choi J, Chandrasekaran K, Demarest TG, Kristian T, Xu S, Vijay-kumar K, Dsouza KG, Qi NR, Yarowsky PJ, Gallipoli R, Koch LG, Fiskum GM, Britton SL, Russell JW. Brain diabetic neurodegeneration segregates with low intrinsic aerobic capacity. Ann Clin Transl Neurol 1: 589-604, 2014.
20. Chowrashi P, Mittal B, Sanger JM, Sanger JW. Amorphin is phos-phorylase; Phosphorylase is an alpha-actinin-binding protein. Cytoskeleton 53: 125-135, 2002.
21. Clarkson PM, Devaney JM, Gordish-Dressman H, Thompson PD, Hubal MJ, Urso M, Price TB, Angelopoulos TJ, Gordon PM, Moyna NM, Pescatello LS, Visich PS, Zoeller RF, Seip RL, Hoffman EP. ACTN3 genotype is associated with increases in muscle strength in response to resistance training in women. J Appl Physiol 99: 154-163, 2005.
22. de Luna N, Brull A, Guiu JM, Lucia A, Martin MA, Arenas J, Marti R, Andreu AL, Pinos T. Sodium valproate increases the brain isoform of glycogen phosphorylase: looking for a compensation mechanism in McArdle disease using a mouse primary skeletal-muscle culture in vitro. Dis Model Mech 8: 467-472, 2015.
23. Delmonico MJ, Zmuda JM, Taylor BC, Cauley JA, Harris TB, Manini TM, Schwartz A, Li R, Roth SM, Hurley BF. Association of the ACTN3 genotype and physical functioning with age in older adults. J Gerontol Ser A Biol Sci Med Sci 63: 1227-1234, 2008.
24. Doring FE, Onur S, Geisen U, Boulay MR, Perusse L, Rankinen T, Rauramaa R, Wolfahrt B, Bouchard C. ACTN3 R577X and other polymorphisms are not associated with elite endurance athlete status in the Genathlete study. J Sports Sci 28: 1355-1359, 2010.
25. Fiuza-Luces C, Soares-Miranda L, Gonzalez-Murillo A, Palacio JM, Colmenero I, Casco F, Melen GJ, Delmiro A, Moran M, Ramirez M, Lucia A. Exercise benefits in chronic graft versus host disease: a murine model study. Med Sci Sports Exerc 45: 1703-1711, 2013.
26. Frey N, Frank D, Lippl S, Kuhn C, Kögler H, Barrientos T, Rohr C, Will R, Müller OJ, Weiler H. Calsarcin-2 deficiency increases exercise capacity in mice through calcineurin/NFAT activation. J Clin Invest 118: 3598, 2008.
27. Garland T Jr, Bennett A, Daniels C. Heritability of locomotor performance and its correlates in a natural population. Experientia 46: 530-533, 1990.
28. Garton FC, Seto JT, Quinlan KG, Yang N, Houweling PJ, North KN. alpha-Actinin-3 deficiency alters muscle adaptation in response to dener-vation and immobilization. Hum Mol Genet 23: 1879-1893, 2014.
29. Gavini CK, Mukherjee S, Shukla C, Britton SL, Koch LG, Shi H, Novak CM. Leanness and heightened nonresting energy expenditure: role of skeletal muscle activity thermogenesis. Am J Physiol Endocrinol Metab 306: E635-E647, 2014.
30. Geel TM, McLaughlin PM, de Leij LF, Ruiters MH, Niezen-Koning KE. Pompe disease: current state of treatment modalities and animal models. Mol Genet Metab 92: 299-307, 2007.
31. Haller RG, Wyrick P, Taivassalo T, Vissing J. Aerobic conditioning: an effective therapy in McArdle’s disease. Ann Neurol 59: 922-928, 2006.
32. He Y, Liu W, Koch LG, Britton SL, Keep RF, Xi G, Hua Y. Susceptibility to intracerebral hemorrhage-induced brain injury segregates with low aerobic capacity in rats. Neurobiol Dis 49: 22-28, 2013.
33. 2+ kinetics associated with alpha-actinin-3 deficiency may explain positive selection for ACTN3 null allele in human evolution. PLoS Genet 11: e1004862, 2015.
34. Hong H, Xu L, Liu J, Jones WD, Su Z, Ning B, Perkins R, Ge W, Miclaus K, Zhang L, Park K, Green B, Han T, Fang H, Lambert CG, Vega SC, Lin SM, Jafari N, Czika W, Wolfinger RD, Goodsaid F, Tong W, Shi L. Technical reproducibility of genotyping SNP arrays used in genome-wide association studies. PLoS One 7: e44483, 2012.
35. Hoydal MA, Stolen TO, Johnsen AB, Alvez M, Catalucci D, Condorelli G, Koch LG, Britton SL, Smith GL, Wisløff U. Reduced aerobic capacity causes leaky ryanodine receptors that trigger arrhythmia in a rat strain artificially selected and bred for low aerobic running capacity. Acta Physiol (Oxf) 210: 854-864, 2014.
36. Hudson JW, Hefferon KL, Crerar MM. Comparative analysis of species-independent, isozyme-specific amino-acid substitutions in mammalian muscle, brain and liver glycogen phosphorylases. Biochim Biophys Acta 1164: 197-208, 1993.
37. Judson RN, Wackerhage H, Hughes A, Mavroeidi A, Barr RJ, Mac-donald HM, Ratkevicius A, Reid DM, Hocking LJ. The functional ACTN3 577X variant increases the risk of falling in older females: results from two large independent cohort studies. J Gerontol A Biol Sci Med Sci 66: 130-135, 2011.
38. Kavanagh T, Mertens DJ, Hamm LF, Beyene J, Kennedy J, Corey P, Shephard RJ. Peak oxygen intake and cardiac mortality in women referred for cardiac rehabilitation. J Am Coll Cardiol 42: 2139-2143, 2003.
39. Kikuchi N, Yoshida S, Min Sk Lee K, Sakamaki-Sunaga M, Okamoto T, Nakazato K. ACTN3 R577X genotype is associated with muscle function in a Japanese population. App Phys Nutr Metab 4: 316-322, 2015.
40. Kimura M, Crow JF. On the maximum avoidance of inbreeding. Genet Res 4: 399-415, 1963.
41. Koch LG, Britton SL. Aerobic metabolism underlies complexity and capacity. J Physiol 586: 83-95, 2008.
42. Koch LG, Britton SL. Artificial selection for intrinsic aerobic endurance running capacity in rats. Physiol Genomics 5: 45-52, 2001.
43. Koch LG, Kemi OJ, Qi N, Leng SX, Bijma P, Gilligan LJ, Wilkinson JE, Wisløff H, Høydal MA, Rolim N, Abadir PM, van Grevenhof EM, Smith GL, Burant CF, Ellingsen O, Britton SL, Wisløff U. Intrinsic aerobic capacity sets a divide for aging and longevity. Circ Res 109: 1162-1172, 2011.
44. Koch LG, Pollott GE, Britton SL. Selectively bred rat model system for low and high response to exercise training. Physiol Genomics 45: 606-614, 2013.
45. Kokkinos P, Myers J, Kokkinos JP, Pittaras A, Narayan P, Manolis A, Karasik P, Greenberg M, Papademetriou V, Singh S. Exercise capacity and mortality in black and white men. Circulation 117: 614-622, 2008.
46. Lek M, North KN. Are biological sensors modulated by their structural scaffolds? The role of the structural muscle proteins-actinin-2 and-actinin-3 as modulators of biological sensors. FEBS Lett 584: 2974-2980, 2010.
47. Lessard SJ, Rivas DA, Alves-Wagner AB, Hirshman MF, Gallagher IJ, Constantin-Teodosiu D, Atkins R, Greenhaff PL, Qi NR, Gustafsson T, Fielding RA, Timmons JA, Britton SL, Koch LG, Goodyear LJ. Resistance to aerobic exercise training causes metabolic dysfunction and reveals novel exercise-regulated signaling networks. Diabetes 62: 2717-2727, 2013.
48. Lim JA, Li L, Raben N. Pompe disease: from pathophysiology to therapy and back again. Front Aging Neurosci 6: 177, 2014.
49. Locke AE, Kahali B, Berndt SI, Justice AE, Pers TH, Day FR, Powell C, Vedantam S, Buchkovich ML, Yang J, Croteau-Chonka DC, Esko T, Fall T, Ferreira T, Gustafsson S, Kutalik Z, Luan Ja Magi R, Randall JC, Winkler TW, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature 518: 197-206, 2015.
50. Lucia A, Nogales-Gadea G, Perez M, Martin MA, Andreu AL, Arenas J. McArdle disease: what do neurologists need to know? Nat Clin Pract Neurol 4: 568-577, 2008.
51. MacArthur DG, Seto JT, Chan S, Quinlan KG, Raftery JM, Turner N, Nicholson MD, Kee AJ, Hardeman EC, Gunning PW, Cooney GJ, Head SI, Yang N, North KN. An Actn3 knockout mouse provides mechanistic insights into the association between alpha-actinin-3 defi-ciency and human athletic performance. Hum Mol Genet 17: 1076-1086, 2008.
52. MacArthur DG, Seto JT, Raftery JM, Quinlan KG, Huttley GA, Hook JW, Lemckert FA, Kee AJ, Edwards MR, Berman Y, Hardeman EC, Gunning PW, Easteal S, Yang N, North KN. Loss of ACTN3 gene function alters mouse muscle metabolism and shows evidence of positive selection in humans. Nat Genet 39: 1261-1265, 2007.
53. Mate-Munoz JL, Moran M, Perez M, Chamorro-Vina C, Gomez-Gallego F, Santiago C, Chicharro L, Foster C, Nogales-Gadea G, Rubio JC, Andreu AL, Martin MA, Arenas J, Lucia A. Favorable responses to acute and chronic exercise in McArdle patients. Clin J Sport Med 17: 297-303, 2007.
54. Mills M, Yang N, Weinberger R, Vander Woude DL, Beggs AH, Easteal S, North K. Differential expression of the actin-binding proteins, alpha-actinin-2 and-3, in different species: implications for the evolution of functional redundancy. Hum Mol Genet 10: 1335-1346, 2001.
55. Mitchell P. Coupling of phosphorylation to electron and hydrogen transfer by a chemi-osmotic type of mechanism. Nature 191: 144-148, 1961.
56. Moran CN, Yang N, Bailey ME, Tsiokanos A, Jamurtas A, MacArthur DG, North K, Pitsiladis YP, Wilson RH. Association analysis of the ACTN3 R577X polymorphism and complex quantitative body com-position and performance phenotypes in adolescent Greeks. Eur J Hum Genet 15: 88-93, 2007.
57. Morris EM, Jackman MR, Johnson GC, Liu TW, Lopez JL, Kearney ML, Fletcher JA, Meers GM, Koch LG, Britton SL, Rector RS, Ibdah JA, MacLean PS, Thyfault JP. Intrinsic aerobic capacity impacts sus-ceptibility to acute high-fat diet-induced hepatic steatosis. Am J Physiol Endocrinol Metab 307: E355-E364, 2014.
58. Muncey A, Saulles A, Baghdoyan HA, Koch LG, Britton SL, Lydic R. Rats bred for low intrinsic aerobic running capacity exhibit decreased and more disrupted sleep compared with those bred for high intrinsic aerobic running capacity. Sleep 31: A27-A28, 2008.
59. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 346: 793-801, 2002.
60. Nilsson MI, MacNeil LG, Kitaoka Y, Suri R, Young SP, Kaczor JJ, Nates NJ, Ansari MU, Wong T, Ahktar M, Brandt L, Hettinga BP, Tarnopolsky MA. Combined aerobic exercise and enzyme replacement therapy rejuvenates the mitochondrial-lysosomal axis and alleviates au-tophagic blockage in Pompe disease. Free Radic Biol Med 87: 98-112, 2015.
61. Nilsson MI, Samjoo IA, Hettinga BP, Koeberl DD, Zhang H, Hawke TJ, Nissar AA, Ali T, Brandt L, Ansari MU, Hazari H, Patel N, Amon J, Tarnopolsky MA. Aerobic training as an adjunctive therapy to enzyme replacement in Pompe disease. Mol Genet Metab 107: 469-479, 2012.
62. Nogales-Gadea G, Brull A, Santalla A, Andreu AL, Arenas J, Martin MA, Lucia A, de Luna N, Pinos T. McArdle disease: update of reported mutations and polymorphisms in the PYGM gene. Hum Mutat 36: 669-678, 2015.
63. Nogales-Gadea G, Consuegra-Garcia I, Rubio JC, Arenas J, Cuadros M, Camara Y, Torres-Torronteras J, Fiuza-Luces C, Lucia A, Martin MA, Garcia-Arumi E, Andreu AL. A transcriptomic approach to search for novel phenotypic regulators in McArdle disease. PLoS One 7: e31718, 2012.
64. Nogales-Gadea G, Pinos T, Lucia A, Arenas J, Camara Y, Brull A, de Luna N, Martin MA, Garcia-Arumi E, Marti R, Andreu AL. Knock-in mice for the R50X mutation in the PYGM gene present with McArdle disease. Brain 135: 2048-2057, 2012.
65. Nogales-Gadea G, Rubio JC, Fernandez-Cadenas I, Garcia-Con-suegra I, Lucia A, Cabello A, Garcia-Arumi E, Arenas J, Andreu AL, Martin MA. Expression of the muscle glycogen phosphorylase gene in patients with McArdle disease: the role of nonsense-mediated mRNA decay. Hum Mutat 29: 277-283, 2008.
66. Nogales-Gadea G, Santalla A, Brull A, de Luna N, Lucia A, Pinos T. The pathogenomics of McArdle disease-genes, enzymes, models, and therapeutic implications. J Inherit Metab Dis 38: 221-230, 2015.
67. Noland RC, Thyfault JP, Henes ST, Whitfield BR, Woodlief TL, Evans JR, Lust JA, Britton SL, Koch LG, Dudek RW, Dohm GL, Cortright RN, Lust RM. Artificial selection for high-capacity endurance running is protective against high-fat diet-induced insulin resistance. Am J Physiol Endocrinol Metab 293: E31-E41, 2007.
68. Norman B, Esbjörnsson M, Rundqvist H, Österlund T, Glenmark B, Jansson E. ACTN3 genotype and modulation of skeletal muscle response to exercise in human subjects. J Appl Physiol 116: 1197-1203, 2014.
69. North KN, Yang N, Wattanasirichaigoon D, Mills M, Easteal S, Beggs AH. A common nonsense mutation results in alpha-actinin-3 deficiency in the general population. Nat Genet 21: 353-354, 1999.
70. Orysiak J, Sitkowski D, Zmijewski P, Malczewska-Lenczowska J, Cieszczyk P, Zembron-Lacny A, Pokrywka A. Overrepresentation of the ACTN3 XX genotype in elite canoe and kayak paddlers. J Strength Cond Res 29: 1107-1112, 2015.
71. Overmyer KA, Evans CR, Qi NR, Minogue CE, Carson JJ, Cherm-side-Scabbo CJ, Koch LG, Britton SL, Pagliarini DJ, Coon JJ, Burant CF. Maximal oxidative capacity during exercise is associated with skeletal muscle fuel selection and dynamic changes in mitochondrial protein acetylation. Cell Metab 21: 468-478, 2015.
72. Pasqua LA, Bueno S, Artioli GG, Lancha AH Jr, Matsuda M, Marquezini MV, Lima-Silva AE, Saldiva PH, Bertuzzi R. Influence of ACTN3 R577X polymorphism on ventilatory thresholds related to endur-ance performance. J Sports Sci: 1-8, 2015.
73. Pedersen BK, Saltin B. Evidence for prescribing exercise as therapy in chronic disease. Scand J Med Sci Sports 16, Suppl 1: 3-63, 2006.
74. Polderman TJC, Benyamin B, de Leeuw CA, Sullivan PF, van Bochoven A, Visscher PM, Posthuma D. Meta-analysis of the heritability of human traits based on fifty years of twin studies. Nat Genet 47: 702-709, 2015.
75. Prigogine I. Time, structure, fluctuations. Science 201: 777-785, 1978.
76. Quinlan KG, Seto JT, Turner N, Vandebrouck A, Floetenmeyer M, Macarthur DG, Raftery JM, Lek M, Yang N, Parton RG.-Actinin-3 deficiency results in reduced glycogen phosphorylase activity and altered calcium handling in skeletal muscle. Hum Mol Genet 19: 1335-1346, 2010.
77. Ren YY, Overmyer KA, Qi NR, Treutelaar MK, Heckenkamp L, Kalahar M, Koch LG, Britton SL, Burant CF, Li JZ. Genetic analysis of a rat model of aerobic capacity and metabolic fitness. PLoS One 8: e77588, 2013.
78. Riedl I, Osler ME, Benziane B, Chibalin AV, Zierath JR. Association of the ACTN3 R577X polymorphism with glucose tolerance and gene expression of sarcomeric proteins in human skeletal muscle. Physiol Rep 3: e12314, 2015.
79. Santalla A, Munguia-Izquierdo D, Brea-Alejo L, Pagola-Aldazabal I, Diez-Bermejo J, Fleck SJ, Ara I, Lucia A. Feasibility of resistance training in adult McArdle patients: clinical outcomes and muscle strength and mass benefits. Front Aging Neurosci 6: 334, 2014.
80. Santalla A, Nogales-Gadea G, Ortenblad N, Brull A, de Luna N, Pinos T, Lucia A. McArdle disease: a unique study model in sports medicine. Sports Med 44: 1531-1544, 2014
81. 2 emission capacities without major shifts in myosin heavy chain isoform. J Appl Physiol (1985) 113: 1624-1634
82. Seto JT, Chan S, Turner N, MacArthur DG, Raftery JM, Berman YD, Quinlan KG, Cooney GJ, Head S, Yang N, North KN. The effect of alpha-actinin-3 deficiency on muscle aging. Exp Gerontol 46: 292-302, 2011.
83. Seto JT, Lek M, Quinlan KG, Houweling PJ, Zheng XF, Garton F, MacArthur DG, Raftery JM, Garvey SM, Hauser MA. Deficiency of-actinin-3 is associated with increased susceptibility to contraction-induced damage and skeletal muscle remodeling. Hum Mol Genet 20: 2914-2927, 2011.
84. Seto JT, Quinlan KG, Lek M, Zheng XF, Garton F, MacArthur DG, Hogarth MW, Houweling PJ, Gregorevic P, Turner N, Cooney GJ, Yang N, North KN. ACTN3 genotype influences muscle performance through the regulation of calcineurin signaling. J Clin Invest 123: 4255-4263, 2013.
85. Shang X, Huang C, Chang Q, Zhang L, Huang T. Association between the ACTN3 R577X polymorphism and female endurance athletes in China. Int J Sports Med 31: 913-916, 2010.
86. Shang X, Zhang F, Zhang L, Huang C. ACTN3 R577X polymorphism and performance phenotypes in young Chinese male soldiers. J Sports Sci 30: 255-260, 2012.
87. Tan P, Allen JG, Wilton SD, Akkari PA, Huxtable CR, Laing NG. A splice-site mutation causing ovine McArdle’s disease. Neuromuscul Disord 7: 336-342, 1997.
88. Thyfault JP, Rector RS, Uptergrove GM, Borengasser SJ, Morris EM, Wei Y, Laye MJ, Burant CF, Qi NR, Ridenhour SE, Koch LG, Britton SL, Ibdah JA. Rats selectively bred for low aerobic capacity have reduced hepatic mitochondrial oxidative capacity and susceptibility to hepatic steatosis and injury. J Physiol 587: 1805-1816, 2009.
89. Van Damme R, Wilson RS, Vanhooydonck B, Aerts P. Evolutionary biology: performance constraints in decathletes. Nature 415: 755-756, 2002.
90. Vincent B, De Bock K, Ramaekers M, Van den Eede E, Van Leemputte M, Hespel P, Thomis MA. ACTN3 (R577X) genotype is associated with fiber type distribution. Physiol Genomics 32: 58-63, 2007.
91. Walsh S, Liu D, Metter EJ, Ferrucci L, Roth SM. ACTN3 genotype is associated with muscle phenotypes in women across the adult age span. J Appl Physiol 105: 1486-1491, 2008.
92. Wikgren J, Mertikas GG, Raussi P, Tirkkonen R, Ayravainen L, Pelto-Huikko M, Koch LG, Britton SL, Kainulainen H. Selective breeding for endurance running capacity affects cognitive but not motor learning in rats. Physiol Behav 106: 95-100, 2012.
93. Wisløff U, Bye A, Stolen T, Kemi OJ, Pollott GE, Pande M, McEachin RC, Britton SL, Koch LG. Blunted cardiomyocyte remodeling response in exercise-resistant rats. J Am Coll Cardiol 65: 1378-1380, 2015.
94. Wisløff U, Najjar SM, Ellingsen Ø, Haram PM, Swoap S, Al-Share Q, Fernström M, Rezaei K, Lee SJ, Koch LG, Britton SL. Cardiovascular risk factors emerge after artificial selection for low aerobic capacity. Science 307: 418-420, 2005.
95. Wolfarth B, Rankinen T, Hagberg JM, Loos RJ, Perusse L, Roth SM, Sarzynski MA, Bouchard C. Advances in exercise, fitness, and performance genomics in 2013. Med Sci Sports Exerc 46: 851-859, 2014.
96. Yang N, Garton F, North K. Alpha-actinin-3 performance. Med Sport Sci 54: 88-101, 2009.
97. Yang N, MacArthur DG, Gulbin JP, Hahn AG, Beggs AH, Easteal S, North K. ACTN3 genotype is associated with human elite athletic performance. Am J Hum Genet 73: 627-631, 2003.
98. Yang N, Schindeler A, McDonald MM, Seto JT, Houweling PJ, Lek M, Hogarth M, Morse AR, Raftery JM, Balasuriya D, MacArthur DG, Berman Y, Quinlan KG, Eisman JA, Nguyen TV, Center JR, Prince RL, Wilson SG, Zhu K, Little DG, North KN. alpha-Actinin-3 deficiency is associated with reduced bone mass in human and mouse. Bone 49: 790-798, 2011.
99. Zempo H, Tanabe K, Murakami H, Iemitsu M, Maeda S, Kuno S. Age differences in the relation between ACTN3 R577X polymorphism and thigh-muscle cross-sectional area in women. Genet Test Mol Biomarkers 15: 639-643, 2011.